|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.20 EUR | -.--% |
|
-.--% | +18.82% |
| Market Cap | 38.47M 33.65M 31.03M 28.69M 54.49M 3.67B 55.42M 372M 146M 1.81B 144M 141M 6.25B | P/E 2017 |
17.4x | P/E 2018 | 19.8x |
|---|---|---|---|---|---|
| Enterprise Value | 36.72M 32.12M 29.62M 27.38M 52.01M 3.5B 52.89M 355M 139M 1.72B 138M 135M 5.96B | EV / Sales 2017 |
1.97x | EV / Sales 2018 | 1.38x |
| Free-Float |
5.42% | Yield 2017 |
3.36% | Yield 2018 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Millet
CEO | Chief Executive Officer | - | 2002-12-08 |
Valérie Chopinet
DFI | Director of Finance/CFO | - | 2006-12-18 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 1998-03-15 | |
Pierre Martin
BRD | Director/Board Member | - | 1998-03-15 |
| Director/Board Member | - | 2011-03-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 42.79M | ||
| +0.85% | +7.41% | +33.91% | -35.07% | 5.86B | ||
| -0.61% | +6.69% | +3.57% | +12.88% | 1.24B | ||
| +0.99% | +8.98% | +8.29% | +17.87% | 466M | ||
| Average | +0.31% | +4.99% | +15.26% | -1.44% | 1.9B | |
| Weighted average by Cap. | +0.62% | +5.30% | +27.35% | -23.94% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 21.86M 19.12M 17.63M 16.3M 30.96M 2.08B 31.49M 211M 82.69M 1.03B 82.06M 80.28M 3.55B | 22.21M 19.43M 17.92M 16.56M 31.46M 2.12B 31.99M 215M 84.01M 1.04B 83.38M 81.56M 3.61B |
| Net income | 2.54M 2.22M 2.05M 1.9M 3.6M 242M 3.66M 24.56M 9.62M 119M 9.54M 9.34M 413M | 1.63M 1.43M 1.32M 1.22M 2.31M 156M 2.35M 15.77M 6.18M 76.62M 6.13M 6M 265M |
| Net Debt | -1.07M -932K -860K -795K -1.51M -102M -1.54M -10.3M -4.03M -50.01M -4M -3.91M -173M | -1.75M -1.53M -1.41M -1.31M -2.48M -167M -2.52M -16.93M -6.63M -82.24M -6.58M -6.44M -285M |
Employees
-
Sector
Drug Retailers
- Stock Market
- Stocks
- ALINN Stock
Select your edition
All financial news and data tailored to specific country editions
















